| お名前 | コメント |
|---|---|
| Theodore | I'd like some euros http://inwa-nordicwalking.com/essay-writing-company/ writing assignment for you The Food and Drug Administration is investigating a reported case of the brain infection progressive multifocal leukoencephalopathy in a patient taking the Novartis MS drug Gilenya in Europe. The regulator announced the investigation Thursday and said in a statement that this is the first case of PML reported in a Gilenya patient who has not taken Biogen Idec's Tysabri, which the regulator notes has been associated with a higher risk of PML. (01/31 15:06 ns322682.ip-188-165-233.eu) |
| [管理用] |
ゆいぼーと(Free) Fvote Falcon World |